Debra Yu - Oct 29, 2021 Form 3 Insider Report for LianBio (LIAN)

Role: President & Chief Strategy Officer Exhibit List: Exhibit 24 - Power of Attorney
Signature: By /s/ Angela Chen, Attorney-in-Fact
Stock symbol: LIAN
Transactions as of: Oct 29, 2021
Transactions value $: $0
Form type: 3
Date filed: 10/29/2021, 06:15 PM
Previous filing: Jul 12, 2021
Next filing: Nov 1, 2021
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	LIAN	Stock Option (Right to Buy)							Oct 29, 2021	Ordinary Shares	2M	$1.71	Direct	F1

Showing 1 to 1 of 1 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	1/3 of the shares underlying the option vested and became exercisable on January 1, 2020; 1/3 of the shares underlying the option vested and became exercisable on October 1, 2020 and 1/3 of the shares underlying the option vested and became exercisable on October 1, 2021, subject to the Reporting Person providing continuous service to the Issuer on each such date.

Remarks:

President & Chief Strategy Officer Exhibit List: Exhibit 24 - Power of Attorney